{
    "2020-10-19": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：冠脉支架国采方案落地 头部企业有望相对受益",
                "features": {
                    "keywords": [
                        "冠脉支架",
                        "国采方案",
                        "头部企业",
                        "受益"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：持续看好流感及肺炎相关疫苗销售 关注医药三季报业绩主线",
                "features": {
                    "keywords": [
                        "流感",
                        "肺炎",
                        "疫苗销售",
                        "三季报",
                        "业绩"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东吴证券：心脏支架集采即将落地 长期看利好国产龙头",
                "features": {
                    "keywords": [
                        "心脏支架",
                        "集采",
                        "国产龙头",
                        "长期利好"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "143公司利润不断改善24家步入绩优股行列",
                "features": {
                    "keywords": [
                        "公司利润",
                        "改善",
                        "绩优股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}